E. W. Fleischman

933 total citations
25 papers, 801 citations indexed

About

E. W. Fleischman is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, E. W. Fleischman has authored 25 papers receiving a total of 801 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 12 papers in Genetics and 5 papers in Pathology and Forensic Medicine. Recurrent topics in E. W. Fleischman's work include Acute Myeloid Leukemia Research (18 papers), Chronic Myeloid Leukemia Treatments (13 papers) and Chronic Lymphocytic Leukemia Research (10 papers). E. W. Fleischman is often cited by papers focused on Acute Myeloid Leukemia Research (18 papers), Chronic Myeloid Leukemia Treatments (13 papers) and Chronic Lymphocytic Leukemia Research (10 papers). E. W. Fleischman collaborates with scholars based in Russia, United States and United Kingdom. E. W. Fleischman's co-authors include E. L. Prigogina, M A Frenkel, E. L. Prigogina, Kopnin Bp, Janet D. Rowley, Stuart Schwartz, James W. Vardiman, Maimon M. Cohen, Michelle M. Le Beau and Tommaso A. Dragani and has published in prestigious journals such as Blood, British Journal of Haematology and Human Genetics.

In The Last Decade

E. W. Fleischman

24 papers receiving 748 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. W. Fleischman Russia 14 522 297 221 215 201 25 801
E. L. Prigogina United States 11 436 0.8× 281 0.9× 139 0.6× 194 0.9× 137 0.7× 15 629
J L Laï France 13 797 1.5× 270 0.9× 372 1.7× 257 1.2× 86 0.4× 23 942
Dieter K. Hossfeld Germany 14 746 1.4× 234 0.8× 304 1.4× 366 1.7× 93 0.5× 24 920
CM Rubin United States 15 847 1.6× 228 0.8× 432 2.0× 376 1.7× 86 0.4× 20 1.0k
JD Rowley United States 10 520 1.0× 202 0.7× 311 1.4× 225 1.0× 108 0.5× 10 808
M Vanrumbeke France 13 438 0.8× 276 0.9× 395 1.8× 174 0.8× 187 0.9× 18 957
CR Bartram Germany 11 453 0.9× 148 0.5× 206 0.9× 309 1.4× 78 0.4× 17 668
J. Treleaven United Kingdom 10 354 0.7× 135 0.5× 177 0.8× 156 0.7× 141 0.7× 17 636
Nicola Foot United Kingdom 14 481 0.9× 213 0.7× 402 1.8× 108 0.5× 157 0.8× 25 837
Marie‐Josée Le Bris France 18 551 1.1× 235 0.8× 420 1.9× 245 1.1× 78 0.4× 55 986

Countries citing papers authored by E. W. Fleischman

Since Specialization
Citations

This map shows the geographic impact of E. W. Fleischman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. W. Fleischman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. W. Fleischman more than expected).

Fields of papers citing papers by E. W. Fleischman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. W. Fleischman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. W. Fleischman. The network helps show where E. W. Fleischman may publish in the future.

Co-authorship network of co-authors of E. W. Fleischman

This figure shows the co-authorship network connecting the top 25 collaborators of E. W. Fleischman. A scholar is included among the top collaborators of E. W. Fleischman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. W. Fleischman. E. W. Fleischman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsaur, Grigory, et al.. (2016). Genetic heterogeneity of infant acute leukemias. Oncohematology. 11(1). 14–23. 1 indexed citations
4.
Nikolaev, A. V., et al.. (2000). Deletion of theAlu-VpA/MycL1 (1p34.3) locus is a negative prognostic sign in human colorectal cancer. Molecular Biology. 34(3). 337–344.
5.
Fleischman, E. W., et al.. (1999). Increased Karyotype Precision Using Fluorescence In Situ Hybridization and Spectral Karyotyping in Patients with Myeloid Malignancies. Cancer Genetics and Cytogenetics. 108(2). 166–170. 24 indexed citations
6.
Fleischman, E. W., et al.. (1999). MLL is involved in a t(2;11)(p21;q23) in a patient with acute myeloblastic leukemia. Genes Chromosomes and Cancer. 24(2). 151–155. 14 indexed citations
7.
Fleischman, E. W., et al.. (1996). Translocation (2;3)(p13;q26) in two cases of myeloid malignancies: Acute myeloblastic leukemia (M2) and blastic phase of chronic myeloid leukemia. Cancer Genetics and Cytogenetics. 87(2). 182–184. 7 indexed citations
8.
Frenkel, M A, et al.. (1994). Blast cells in child and adult AML: comparative study of morphocytochemical, immunological and cytogenetic characteristics. British Journal of Haematology. 87(4). 708–714. 2 indexed citations
9.
Dragani, Tommaso A., et al.. (1993). 11q deletions in human colorectal carcinomas: Cytogenetics and restriction fragment length polymorphism analysis. Genes Chromosomes and Cancer. 6(1). 45–50. 59 indexed citations
10.
Fleischman, E. W., et al.. (1992). Translocations (17;20) in colorectal adenocarcinomas. Cancer Genetics and Cytogenetics. 64(2). 183–185. 2 indexed citations
11.
Fleischman, E. W., et al.. (1991). Karyotype pecularities of human colorectal adenocarcinomas. Human Genetics. 86(5). 491–6. 29 indexed citations
12.
Fleischman, E. W., et al.. (1989). Chromosomal characteristics of malignant lymphoma. Human Genetics. 82(4). 343–8. 33 indexed citations
13.
Prigogina, E. L., et al.. (1986). Chromosomes in acute nonlymphocytic leukemia. Human Genetics. 73(2). 137–146. 67 indexed citations
14.
Vardiman, James W., Michelle M. Le Beau, Janet D. Rowley, et al.. (1985). Increased numbers of marrow basophils may be associated with a t(6;9) in ANLL. American Journal of Hematology. 18(4). 393–403. 76 indexed citations
15.
Fleischman, E. W., et al.. (1983). Chromosomal rearrangements with a common breakpoint at 6p23 in five cases of myeloid leukemia. Human Genetics. 64(3). 254–256. 24 indexed citations
16.
Fleischman, E. W., et al.. (1981). Correlations between the clinical course, characteristics of blast cells, and karyotype patterns in chronic myeloid leukemia. Human Genetics. 58(3). 285–293. 41 indexed citations
17.
Prigogina, E. L., et al.. (1979). Chromosomes in acute leukemia. Human Genetics. 53(1). 5–16. 136 indexed citations
18.
Prigogina, E. L., et al.. (1978). Chromosome abnormalities and clinical and morphologic manifestations of chronic myeloid leukemia. Human Genetics. 41(2). 143–56. 76 indexed citations
19.
Fleischman, E. W., et al.. (1977). Unusual translocation (10;22) in chronic myelogenous leukemia. Human Genetics. 39(1). 127–129. 11 indexed citations
20.
Fleischman, E. W. & E. L. Prigogina. (1975). G banding in cytogenetic study of hemoblastoses. Human Genetics. 26(4). 335–42. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026